However, GLP-1s accounted for over 8% of all Medicaid prescription drug spending before rebates in 2024 (up from 1% in 2019)
With these tips, youre prepared to use your accounts like a pro
Contemporary OB-GYN: FDA approves-5-year-use-for-etonogestrel-implant-68-mg-contraceptive Safety Labeling Update for Nexplanon Patient Experiences with Nexplanon Summary of MedWatch Voluntary Reports for Nexplanon (240 reports of device complications for 1,577 reports submitted voluntarily, mainly by consumers) Rare Disease: FDA Approves First Treatment for Children With Menkes Disease The FDA approved the first-ever treatment for Menkes disease: Zydus Life Sciences Zycubo (copper histidinate) daily subcutaneous injection for pediatric patients
Another trial, at the National Institute on Drug Abuse, is recruiting participants to see whether GLP-1s could help people with alcohol use disorder drink less
Vendors operating within legal frameworks clearly state that their research peptides comply with FDA regulations for laboratory use
Gallbladder-related risks are heightened during rapid weight loss, as demonstrated in trials of GLP-1 therapies and in dietary interventions such as very-low-calorie diets [33,36]
